Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Jul 15;98(2):336–344. doi: 10.1172/JCI118797

Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes. Evidence that IL-1-inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease.

R W Groves 1, T Rauschmayr 1, K Nakamura 1, S Sarkar 1, I R Williams 1, T S Kupper 1
PMCID: PMC507435  PMID: 8755642

Abstract

Interleukin (IL)-1 induces a cascade of secondary cytokines in a large number of cell types in vitro, including monocytes, fibroblasts, synovial cells, and keratinocytes. Although it has been proposed that autocrine or paracrine activation of such cells by IL- 1 in situ could orchestrate a local inflammatory response, formal proof for such an hypothesis has been lacking. In an attempt to lower the threshold for secondary cytokine production in these cells in response to IL-1, we have generated transgenic mice (designated IR10) which overexpress functional type 1 IL-1 receptor in basal layer of epidermis keratinocytes. As predicted, keratinocytes from these animals were substantially more responsive to exogenous IL-1 than nontransgenic keratinocytes when stimulated in vitro. When challenged with known inducers of keratinocyte IL-1 synthesis and release, skin of IR10 mice exhibited an exaggerated inflammatory response, characterized by epidermal hyperplasia and an acute dermal inflammatory cell infiltrate. In this setting, the secondary epidermal cytokines gro-alpha and GM-CSF were strongly induced in transgenic epidermis but not in control skin. To confirm that these changes were indeed related to IL-1 mediated activation pathways, IR10 mice were crossed to a distinct line of transgenic mice that overexpress 17-kD IL-l alpha in basal keratinocytes. Double transgenic mice derived from this cross breeding experiment developed spontaneous inflammation of the skin, similar in appearance to that induced by PMA, both histologically and macroscopically, and distinct from that seen in either parental strain spontaneously. Furthermore, secondary cytokines were more strongly induced in the double transgenic than in either parental strain. These findings conclusively demonstrate the potential for functional autocrine pathways of keratinocyte activation mediated by IL-1 alpha in vivo, and suggest that level of expression of type 1 IL-1 receptor may function as a significant control point in physiologic IL-1 mediated autocrine pathways.

Full Text

The Full Text of this article is available as a PDF (555.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anttila H. S., Reitamo S., Erkko P., Miettinen A., Didierjean L., Saurat J. H. Membrane and cytosolic interleukin-1 alpha and beta in normal human epidermal cells: variability of epitope exposure in immunohistochemistry. J Invest Dermatol. 1990 Jul;95(1):31–38. doi: 10.1111/1523-1747.ep12873278. [DOI] [PubMed] [Google Scholar]
  2. Bigler C. F., Norris D. A., Weston W. L., Arend W. P. Interleukin-1 receptor antagonist production by human keratinocytes. J Invest Dermatol. 1992 Jan;98(1):38–44. doi: 10.1111/1523-1747.ep12494196. [DOI] [PubMed] [Google Scholar]
  3. Blanton R. A., Kupper T. S., McDougall J. K., Dower S. Regulation of interleukin 1 and its receptor in human keratinocytes. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1273–1277. doi: 10.1073/pnas.86.4.1273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Colotta F., Re F., Muzio M., Bertini R., Polentarutti N., Sironi M., Giri J. G., Dower S. K., Sims J. E., Mantovani A. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science. 1993 Jul 23;261(5120):472–475. doi: 10.1126/science.8332913. [DOI] [PubMed] [Google Scholar]
  5. Cooper K. D., Hammerberg C., Baadsgaard O., Elder J. T., Chan L. S., Sauder D. N., Voorhees J. J., Fisher G. IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta. J Immunol. 1990 Jun 15;144(12):4593–4603. [PubMed] [Google Scholar]
  6. Curtis B. M., Gallis B., Overell R. W., McMahan C. J., DeRoos P., Ireland R., Eisenman J., Dower S. K., Sims J. E. T-cell interleukin 1 receptor cDNA expressed in Chinese hamster ovary cells regulates functional responses to interleukin 1. Proc Natl Acad Sci U S A. 1989 May;86(9):3045–3049. doi: 10.1073/pnas.86.9.3045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Deyerle K. L., Sims J. E., Dower S. K., Bothwell M. A. Pattern of IL-1 receptor gene expression suggests role in noninflammatory processes. J Immunol. 1992 Sep 1;149(5):1657–1665. [PubMed] [Google Scholar]
  8. Dinarello C. A. Biology of interleukin 1. FASEB J. 1988 Feb;2(2):108–115. [PubMed] [Google Scholar]
  9. Dower S. K., Sims J. E., Cerretti D. P., Bird T. A. The interleukin-1 system: receptors, ligands and signals. Chem Immunol. 1992;51:33–64. [PubMed] [Google Scholar]
  10. Eisenberg S. P., Brewer M. T., Verderber E., Heimdal P., Brandhuber B. J., Thompson R. C. Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5232–5236. doi: 10.1073/pnas.88.12.5232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gahring L. C., Buckley A., Daynes R. A. Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum. J Clin Invest. 1985 Oct;76(4):1585–1591. doi: 10.1172/JCI112141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gearing A. J., Fincham N. J., Bird C. R., Wadhwa M., Meager A., Cartwright J. E., Camp R. D. Cytokines in skin lesions of psoriasis. Cytokine. 1990 Jan;2(1):68–75. doi: 10.1016/1043-4666(90)90045-u. [DOI] [PubMed] [Google Scholar]
  13. Goldminz D., Kupper T. S., McGuire J. Keratinocyte membrane-associated epidermal cell-derived thymocyte-activating factor (ETAF). J Invest Dermatol. 1987 Jan;88(1):97–100. doi: 10.1111/1523-1747.ep12465135. [DOI] [PubMed] [Google Scholar]
  14. Groves R. W., Giri J., Sims J., Dower S. K., Kupper T. S. Inducible expression of type 2 IL-1 receptors by cultured human keratinocytes. Implications for IL-1-mediated processes in epidermis. J Immunol. 1995 Apr 15;154(8):4065–4072. [PubMed] [Google Scholar]
  15. Groves R. W., Mizutani H., Kieffer J. D., Kupper T. S. Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis. Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11874–11878. doi: 10.1073/pnas.92.25.11874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Groves R. W., Sherman L., Mizutani H., Dower S. K., Kupper T. S. Detection of interleukin-1 receptors in human epidermis. Induction of the type II receptor after organ culture and in psoriasis. Am J Pathol. 1994 Nov;145(5):1048–1056. [PMC free article] [PubMed] [Google Scholar]
  17. Hammerberg C., Arend W. P., Fisher G. J., Chan L. S., Berger A. E., Haskill J. S., Voorhees J. J., Cooper K. D. Interleukin-1 receptor antagonist in normal and psoriatic epidermis. J Clin Invest. 1992 Aug;90(2):571–583. doi: 10.1172/JCI115896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Haskill S., Martin G., Van Le L., Morris J., Peace A., Bigler C. F., Jaffe G. J., Hammerberg C., Sporn S. A., Fong S. cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc Natl Acad Sci U S A. 1991 May 1;88(9):3681–3685. doi: 10.1073/pnas.88.9.3681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hauser C., Saurat J. H., Schmitt A., Jaunin F., Dayer J. M. Interleukin 1 is present in normal human epidermis. J Immunol. 1986 May 1;136(9):3317–3323. [PubMed] [Google Scholar]
  20. Kristensen M., Deleuran B., Eedy D. J., Feldmann M., Breathnach S. M., Brennan F. M. Distribution of interleukin 1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin 1 alpha in normal and psoriatic skin. Decreased expression of IRAP in psoriatic lesional epidermis. Br J Dermatol. 1992 Oct;127(4):305–311. doi: 10.1111/j.1365-2133.1992.tb00446.x. [DOI] [PubMed] [Google Scholar]
  21. Kupper T. S., Groves R. W. The interleukin-1 axis and cutaneous inflammation. J Invest Dermatol. 1995 Jul;105(1 Suppl):62S–66S. doi: 10.1111/1523-1747.ep12316087. [DOI] [PubMed] [Google Scholar]
  22. Kupper T. S. Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. J Clin Invest. 1990 Dec;86(6):1783–1789. doi: 10.1172/JCI114907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kupper T. S., Lee F., Birchall N., Clark S., Dower S. Interleukin 1 binds to specific receptors on human keratinocytes and induces granulocyte macrophage colony-stimulating factor mRNA and protein. A potential autocrine role for interleukin 1 in epidermis. J Clin Invest. 1988 Nov;82(5):1787–1792. doi: 10.1172/JCI113792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lee W. Y., Lockniskar M. F., Fischer S. M. Interleukin-1 alpha mediates phorbol ester-induced inflammation and epidermal hyperplasia. FASEB J. 1994 Oct;8(13):1081–1087. [PubMed] [Google Scholar]
  25. Muzio M., Polentarutti N., Sironi M., Poli G., De Gioia L., Introna M., Mantovani A., Colotta F. Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist. J Exp Med. 1995 Aug 1;182(2):623–628. doi: 10.1084/jem.182.2.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Oberyszyn T. M., Sabourin C. L., Bijur G. N., Oberyszyn A. S., Boros L. G., Robertson F. M. Interleukin-1 alpha gene expression and localization of interleukin-1 alpha protein during tumor promotion. Mol Carcinog. 1993;7(4):238–248. doi: 10.1002/mc.2940070406. [DOI] [PubMed] [Google Scholar]
  27. Re F., Muzio M., De Rossi M., Polentarutti N., Giri J. G., Mantovani A., Colotta F. The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J Exp Med. 1994 Feb 1;179(2):739–743. doi: 10.1084/jem.179.2.739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sims J. E., Acres R. B., Grubin C. E., McMahan C. J., Wignall J. M., March C. J., Dower S. K. Cloning the interleukin 1 receptor from human T cells. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8946–8950. doi: 10.1073/pnas.86.22.8946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sims J. E., March C. J., Cosman D., Widmer M. B., MacDonald H. R., McMahan C. J., Grubin C. E., Wignall J. M., Jackson J. L., Call S. M. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science. 1988 Jul 29;241(4865):585–589. doi: 10.1126/science.2969618. [DOI] [PubMed] [Google Scholar]
  30. Simón C., Frances A., Piquette G., Polan M. L. Immunohistochemical localization of the interleukin-1 system in the mouse ovary during follicular growth, ovulation, and luteinization. Biol Reprod. 1994 Feb;50(2):449–457. doi: 10.1095/biolreprod50.2.449. [DOI] [PubMed] [Google Scholar]
  31. Sporn M. B., Roberts A. B. Autocrine secretion--10 years later. Ann Intern Med. 1992 Sep 1;117(5):408–414. doi: 10.7326/0003-4819-117-5-408. [DOI] [PubMed] [Google Scholar]
  32. Vassar R., Fuchs E. Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation. Genes Dev. 1991 May;5(5):714–727. doi: 10.1101/gad.5.5.714. [DOI] [PubMed] [Google Scholar]
  33. Williams I. R., Kupper T. S. Epidermal expression of intercellular adhesion molecule 1 is not a primary inducer of cutaneous inflammation in transgenic mice. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9710–9714. doi: 10.1073/pnas.91.21.9710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ye K., Dinarello C. A., Clark B. D. Identification of the promoter region of human interleukin 1 type I receptor gene: multiple initiation sites, high G+C content, and constitutive expression. Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2295–2299. doi: 10.1073/pnas.90.6.2295. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES